Fields »
ABOUT
HELP
BLOG

784 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 16 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
CLDN6Claudin 6
Endometrial cancer: 2.42e-6
Urothelial cancer: 1.78e-4
Tissue enhancedplacenta:1.0
testis:1.8
CYFIP2Cytoplasmic FMR1 interacting protein 2
Endoplasmic reticulum
Plasma membrane
Cytosol		Renal cancer: 3.21e-12
Endometrial cancer: 2.42e-6
Pancreatic cancer: 1.18e-4
Expressed in all
TPX2TPX2, microtubule-associated
Nucleoplasm
Mitotic spindle		Renal cancer: 0.00e+0
Liver cancer: 8.07e-7
Endometrial cancer: 2.43e-6
Pancreatic cancer: 2.68e-5
Lung cancer: 6.46e-4
Tissue enhancedtestis:55.4
C5orf34Chromosome 5 open reading frame 34
Endometrial cancer: 2.65e-6
Tissue enhancedtestis:7.9
SSC4DScavenger receptor cysteine rich family, 4 domainsN/A
Endometrial cancer: 2.83e-6
Renal cancer: 4.71e-4
Glioma: 6.31e-4
Group enriched5kidney:1.4
parathyroid gland:4.1
thyroid gland:2.0
GPR173G protein-coupled receptor 173
Plasma membrane
Cytosol		Endometrial cancer: 2.88e-6
Pancreatic cancer: 2.33e-5
Renal cancer: 2.47e-4
Tissue enhancedcerebral cortex:19.1
PNOCPrepronociceptin
Endometrial cancer: 2.94e-6
Tissue enhancedcerebral cortex:44.3
fallopian tube:26.0
lymph node:29.3
RSPO4R-spondin 4N/A
Endometrial cancer: 2.98e-6
Tissue enhancedlung:6.8
CMSS1Cms1 ribosomal small subunit homolog (yeast)
Nucleus
Nuclear membrane
Nucleoli
Mitochondria		Liver cancer: 5.92e-10
Endometrial cancer: 3.15e-6
Prostate cancer: 3.10e-4
Expressed in all
CILP2Cartilage intermediate layer protein 2N/A
Endometrial cancer: 3.22e-6
Ovarian cancer: 2.50e-4
Tissue enhancedgallbladder:2.5
testis:4.2
LRP8Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
Endometrial cancer: 3.46e-6
Lung cancer: 7.02e-4
Group enriched7cerebral cortex:25.2
testis:47.4
thyroid gland:87.3
RARGRetinoic acid receptor, gamma
NucleoplasmRenal cancer: 3.08e-6
Endometrial cancer: 3.68e-6
Tissue enhancedskin:143.7
INPP4AInositol polyphosphate-4-phosphatase type I A
Nucleus
Nuclear membrane		Endometrial cancer: 3.70e-6
Expressed in all
PRKCIProtein kinase C, iota
Microtubules
Cytokinetic bridge
Cytosol		Endometrial cancer: 3.93e-6
Pancreatic cancer: 1.22e-4
Liver cancer: 3.02e-4
Renal cancer: 3.10e-4
Expressed in all
CDKN2BCyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
NucleoplasmEndometrial cancer: 4.47e-6
Renal cancer: 1.03e-4
Liver cancer: 1.49e-4
Mixed
SLC38A1Solute carrier family 38, member 1
Liver cancer: 6.95e-8
Endometrial cancer: 4.76e-6
Expressed in all
TMEM185BTransmembrane protein 185BN/A
Endoplasmic reticulumLiver cancer: 5.71e-7
Endometrial cancer: 4.96e-6
Colorectal cancer: 5.44e-4
Expressed in all
CRTAC1Cartilage acidic protein 1
Endometrial cancer: 5.01e-6
Urothelial cancer: 1.51e-4
Renal cancer: 1.85e-4
Tissue enhancedcerebral cortex:51.1
fallopian tube:62.9
lung:76.5
seminal vesicle:47.6
KLF12Kruppel-like factor 12
Nucleoplasm
Cytosol		Endometrial cancer: 5.03e-6
Mixed
AIM1LAbsent in melanoma 1-likeN/A
NucleoplasmEndometrial cancer: 5.11e-6
Pancreatic cancer: 3.53e-4
Tissue enhancedesophagus:50.7
skin:21.6
MALMal, T-cell differentiation protein
CentrosomeRenal cancer: 3.96e-9
Endometrial cancer: 5.18e-6
Tissue enriched7esophagus:2459.4
SH3BP2SH3-domain binding protein 2
Nucleus
Actin filaments		Endometrial cancer: 5.42e-6
Head and neck cancer: 1.57e-5
Urothelial cancer: 2.67e-4
Expressed in all
PFKMPhosphofructokinase, muscle
Endoplasmic reticulumRenal cancer: 2.28e-7
Endometrial cancer: 5.85e-6
Head and neck cancer: 7.91e-5
Expressed in all
MEPCEMethylphosphate capping enzyme
Nucleoplasm
Cell Junctions		Renal cancer: 1.01e-10
Endometrial cancer: 6.01e-6
Expressed in all
RPP40Ribonuclease P/MRP 40kDa subunitN/A
NucleoplasmRenal cancer: 7.54e-8
Endometrial cancer: 6.10e-6
Liver cancer: 5.41e-4
Mixed
CCNE1Cyclin E1
NucleoplasmEndometrial cancer: 6.35e-6
Liver cancer: 3.89e-5
Ovarian cancer: 2.97e-4
Tissue enhancedplacenta:44.3
TM9SF4Transmembrane 9 superfamily protein member 4
MitochondriaEndometrial cancer: 6.37e-6
Liver cancer: 2.15e-4
Expressed in all
RASL10BRAS-like, family 10, member B
VesiclesEndometrial cancer: 6.38e-6
Tissue enhancedadipose tissue:15.9
seminal vesicle:20.7
PRSS1Protease, serine, 1 (trypsin 1)
Endometrial cancer: 6.41e-6
Thyroid cancer: 4.91e-4
Ovarian cancer: 7.05e-4
Tissue enriched316pancreas:81582.7
GAL3ST3Galactose-3-O-sulfotransferase 3
Endometrial cancer: 6.53e-6
Tissue enhancedcerebral cortex:4.3
endometrium:4.3
smooth muscle:4.7
thyroid gland:8.2
SLCO3A1Solute carrier organic anion transporter family, member 3A1
Endometrial cancer: 6.57e-6
Cervical cancer: 8.61e-4
Mixed
TMEM41ATransmembrane protein 41A
Nucleoplasm
Golgi apparatus
Cytosol		Endometrial cancer: 6.70e-6
Liver cancer: 1.04e-4
Pancreatic cancer: 4.72e-4
Expressed in all
FOXO6Forkhead box O6
Endometrial cancer: 7.65e-6
Tissue enhancedcerebral cortex:1.7
SNX24Sorting nexin 24
VesiclesEndometrial cancer: 7.93e-6
Renal cancer: 1.28e-4
Liver cancer: 8.88e-4
Expressed in all
RNF114Ring finger protein 114
Plasma membrane
Cytosol		Endometrial cancer: 8.10e-6
Thyroid cancer: 3.01e-4
Liver cancer: 3.11e-4
Expressed in all
MXD1MAX dimerization protein 1
Nucleoplasm
Mitochondria
Cytosol		Endometrial cancer: 8.14e-6
Pancreatic cancer: 8.50e-4
Tissue enhancedbone marrow:114.0
esophagus:102.3
BARX1BARX homeobox 1
Nucleoplasm
Vesicles		Endometrial cancer: 8.16e-6
Head and neck cancer: 1.02e-4
Tissue enriched7stomach:11.2
SLC16A1Solute carrier family 16 (monocarboxylate transporter), member 1
Plasma membrane
Cell Junctions		Renal cancer: 6.78e-8
Endometrial cancer: 8.37e-6
Pancreatic cancer: 2.10e-4
Lung cancer: 4.05e-4
Mixed
CPVLCarboxypeptidase, vitellogenic-like
Endoplasmic reticulumEndometrial cancer: 8.56e-6
Urothelial cancer: 4.99e-4
Expressed in all
SRD5A1Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
Endometrial cancer: 8.73e-6
Mixed
SIX1SIX homeobox 1
Nucleus
Nucleoli		Endometrial cancer: 8.92e-6
Lung cancer: 3.94e-4
Group enriched6cervix, uterine:23.0
parathyroid gland:57.4
prostate:21.5
salivary gland:21.7
skeletal muscle:41.5
PPP3R1Protein phosphatase 3, regulatory subunit B, alpha
Plasma membrane
Cytosol		Endometrial cancer: 9.08e-6
Renal cancer: 1.70e-5
Liver cancer: 5.37e-4
Expressed in all
SNTA1Syntrophin, alpha 1
Endometrial cancer: 9.60e-6
Pancreatic cancer: 3.72e-4
Melanoma: 7.08e-4
Expressed in all
NAT8LN-acetyltransferase 8-like (GCN5-related, putative)
MitochondriaEndometrial cancer: 1.01e-5
Group enriched7adipose tissue:48.6
cerebral cortex:65.1
testis:19.0
ITGB1BP1Integrin beta 1 binding protein 1
Nucleoplasm
Cytosol		Endometrial cancer: 1.03e-5
Liver cancer: 4.67e-5
Renal cancer: 7.10e-5
Expressed in all
EPHB2EPH receptor B2
Nucleus
Plasma membrane		Endometrial cancer: 1.05e-5
Colorectal cancer: 4.98e-4
Mixed
FXYD6FXYD domain containing ion transport regulator 6
Nucleoplasm
Cytosol		Endometrial cancer: 1.05e-5
Renal cancer: 4.38e-5
Urothelial cancer: 1.60e-4
Liver cancer: 5.87e-4
Pancreatic cancer: 5.97e-4
Expressed in all
DHCR2424-dehydrocholesterol reductase
Endometrial cancer: 1.05e-5
Expressed in all
BRIX1BRX1, biogenesis of ribosomes
NucleoliRenal cancer: 3.07e-9
Liver cancer: 4.11e-8
Endometrial cancer: 1.10e-5
Breast cancer: 2.18e-4
Ovarian cancer: 6.34e-4
Expressed in all
BCAMBasal cell adhesion molecule (Lutheran blood group)
Nucleoli fibrillar centerRenal cancer: 5.94e-6
Endometrial cancer: 1.24e-5
Colorectal cancer: 2.31e-4
Expressed in all

« prev | Page of 16 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.